Suzanne A Fuqua
Suzanne A Fuqua
Unknown affiliation
Verified email at
Cited by
Cited by
Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer
CK Osborne, V Bardou, TA Hopp, GC Chamness, SG Hilsenbeck, ...
Journal of the National Cancer Institute 95 (5), 353-361, 2003
Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer
DC Allred, GM Clark, R Elledge, SAW Fuqua, RW Brown, GC Chamness, ...
JNCI: Journal of the National Cancer Institute 85 (3), 200-206, 1993
Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer
MD Burstein, A Tsimelzon, GM Poage, KR Covington, A Contreras, ...
Clinical Cancer Research 21 (7), 1688-1698, 2015
International union of pharmacology. LXIV. Estrogen receptors
K Dahlman-Wright, V Cavailles, SA Fuqua, VC Jordan, ...
Pharmacological reviews 58 (4), 773-781, 2006
Biological and clinical implications of heat shock protein 27000 (Hsp27): a review
DR Ciocca, S Oesterreich, GC Chamness, WL MCGuire, SAW Fuqua
JNCI: Journal of the National Cancer Institute 85 (19), 1558-1570, 1993
HER-2/neu amplification predicts poor survival in node-positive breast cancer
┼ Borg, AK Tandon, H Sigurdsson, GM Clark, M Fern÷, SAW Fuqua, ...
Cancer research 50 (14), 4332-4337, 1990
Variant human breast tumor estrogen receptor with constitutive transcriptional activity
SAW Fuqua, SD Fitzgerald, GC Chamness, AK Tandon, DP McDonnell, ...
Cancer Research 51 (1), 105-109, 1991
Histological and biological evolution of human premalignant breast disease.
DC Allred, SK Mohsin, SA Fuqua
Endocrine-related cancer 8 (1), 47-61, 2001
Estrogen receptor mutations in human disease
MH Herynk, SAW Fuqua
Endocrine reviews 25 (6), 869-898, 2004
Heat shock protein hsp70 in patients with axillary lymph node-negative breast cancer: prognostic implications
DR Ciocca, GM Clark, AK Tandon, SAW Fuqua, WJ Welch, WL McGuire
JNCI: Journal of the National Cancer Institute 85 (7), 570-574, 1993
Selective estrogen receptor modulators: structure, function, and clinical use
CK Osborne, H Zhao, SAW Fuqua
Journal of Clinical Oncology 18 (17), 3172-3186, 2000
Direct acetylation of the estrogen receptor α hinge region by p300 regulates transactivation and hormone sensitivity
C Wang, M Fu, RH Angeletti, L Siconolfi-Baez, AT Reutens, C Albanese, ...
Journal of Biological Chemistry 276 (21), 18375-18383, 2001
Estrogen receptor and breast cancer
S Sommer, SAW Fuqua
Seminars in cancer biology 11 (5), 339-352, 2001
Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci
P O'Connell, V Pekkel, DC Allred, SAW Fuqua, CK Osborne, GM Clark
JNCI: Journal of the National Cancer Institute 90 (9), 697-703, 1998
A renewable tissue resource of phenotypically stable, biologically and ethnically diverse, patient-derived human breast cancer xenograft models
X Zhang, S Claerhout, A Prat, LE Dobrolecki, I Petrovic, Q Lai, MD Landis, ...
Cancer research 73 (15), 4885-4897, 2013
Response of human breast cancer cells to heat shock and chemotherapeutic drugs
DR Ciocca, SAW Fuqua, S Lock-Lim, DO Toft, WJ Welch, WL McGuire
Cancer research 52 (13), 3648-3654, 1992
Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer.
JJ Isola, OP Kallioniemi, LW Chu, SA Fuqua, SG Hilsenbeck, CK Osborne, ...
The American journal of pathology 147 (4), 905, 1995
Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors
SAW Fuqua, SD Fitzgerald, DC Allred, RM Elledge, Z Nawaz, ...
Cancer research 52 (2), 483-486, 1992
MINIREVIEW: Estrogen Receptor Variants in Clinical Breast Cancer
WL McGuire, GC Chamness, SAW Fuqua
Molecular Endocrinology 5 (11), 1571-1577, 1991
An estrogen receptor mutant with strong hormone-independent activity from a metastatic breast cancer
QX Zhang, ┼ Borg, DM Wolf, S Oesterreich, SAW Fuqua
Cancer research 57 (7), 1244-1249, 1997
The system can't perform the operation now. Try again later.
Articles 1–20